胰高血糖素受体 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-20. Anything still debated is marked as such rather than presented as settled.
化学修饰延长了分子在体内的停留时间，使较低频次的给药安排成为可能。脂肪酸侧链通过与白蛋白结合延缓清除，非天然氨基酸则降低酶解速率。这些修饰同时改变分子的溶解性与稳定性，需要在制剂设计和储存条件中一并考虑。修饰引入的免疫原性风险也属于开发过程中需要评估的项目。
该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
| Property | Value | Notes |
|---|---|---|
| 分子类别 | 合成多肽 | 含非天然氨基酸与脂肪酸侧链 |
| 分子量 | 约 4.7 kDa | 多肽量级，精确值随计法而异 |
| 外观 | 白色至类白色冻干粉 | 常见冻干形态，供复溶使用 |
| 溶解性 | 易溶于水 | 复溶后为澄清至微乳光液体 |
| 常见同义词 | LY3437943 | 开发阶段使用的代号 |
该分子是经过结构修饰的合成肽，通过脂肪酸侧链与白蛋白结合，从而延长循环时间。皮下给药后，药物逐步释放并分布至组织。降解主要依赖蛋白酶，肾脏清除占次要地位。人体半衰期以天为单位，但准确数值随检测方法和个体差异而变；组织分布与受体占有率仍是开放问题。
临床研究通常测量体重、腰围、空腹血糖、糖化血红蛋白和血脂，并记录不良事件。药代动力学评估关注浓度-时间曲线，药效动力学评估关注代谢标志物变化。体重下降由能量摄入减少、能量消耗变化和脂肪组织重塑共同造成，具体权重仍不明确。研究之间的终点定义和随访时长差异使横向比较复杂。
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
=== Analogues === Analogues of muscimol include γ-aminobutyric acid (GABA), ibotenic acid, dihydromuscimol, thiomuscimol, piperidine-4-sulphonic acid (P4S), gaboxadol (THIP), 4-AHP, 4-PIOL, isonipecotic acid, guvacine, isoguvacine, THPO, nipecotic acid, and tiagabine, among others. In contrast to the preceding compounds, certain other analogues, including isomuscimol and azamuscimol, are virtually inactive. The structural requirements for GABAA receptor binding and activation are very strict, so relatively few high-efficacy GABAA receptor agonists are known.
==== Alanine ==== The ammonia produced in neurons is fixed into α-ketoglutarate by the glutamate-dehydrogenase reaction to form glutamate, then transaminated by alanine aminotransferase into lactate-derived pyruvate to form alanine, which is exported to astrocytes. In the astrocytes, this process is then reversed, and lactate is transported in the other direction.
The Familia AP (323 in most of the world, GLC for "Great Little Car" in North America) debuted in January 1977 as a rear-wheel-drive subcompact, replacing both the Grand Familia (818) and the preceding Familia (1000/1300). There was a choice of hatchbacks and station wagon bodies, both available with a three- or five-door bodystyle. The station wagon version was a bit later, first being introduced in June 1978, which also meant that the commercial versions based on the 1970 Familia could finally be retired. Three Mazda engines were available, the 985 cc PC, 1,272 cc TC, and the 1415 cc UC (introduced in March 1978). The 1.0-litre unit was only made for export markets. The new Familia shared many parts with the older Mazda Grand Familia. This was the first appearance of the 323 name, for export markets only. The Familia AP was marketed to a new kind of consumer, the Japanese youth, and sold well at home as well as abroad. Nonetheless, the cars traditional rear-wheel-drive underpinnings limited interior space and betrayed themselves in having a very narrow track when compared to the body. The FA4 was somewhat of an interim solution while Mazda worked on a front-wheel-drive car, but still managed to sell around 890,000 examples in its three full years of production. In June 1979, the 323/Familia underwent a facelift, replacing the previous round headlights with rectangular units which were designed as a single unit along with the grille. The new style was in line with that of the recently released Mazda Capella/626 (CB).
Sources: en.wikipedia.org
The El Niño–Southern Oscillation is a single climate phenomenon that recurs in three phases: Neutral, La Niña or El Niño. La Niña and El Niño are opposite phases in the oscillation which are deemed to occur when specific ocean and atmospheric conditions are reached or exceeded. The warming phase of the sea surface temperature is known as "El Niño", and its cooling phase as "La Niña". The "Southern Oscillation" is the oscillation in surface air pressure between the tropical eastern Pacific Ocean waters and the tropical western Pacific Ocean waters. An early recorded mention of the term "El Niño" ("The Boy" in Spanish) in a climate context occurred in 1892, when Captain Camilo Carrillo reported to the geographical society congress in Lima that Peruvian sailors named the warm, south-flowing current after the Christ Child, as it typically appeared around Christmas. Over time, the term has evolved and now refers to the warm and negative phase of the El Niño–Southern Oscillation (ENSO). The original phrase, El Niño de Navidad 'The Christmas Boy', arose centuries ago, when Peruvian fishermen named the weather phenomenon after the newborn Christ. La Niña ("The Girl" in Spanish) is the colder counterpart of El Niño, as part of the broader ENSO climate pattern. In the past, it was also called an anti-El Niño and El Viejo 'the old man'.
Radiocarbon dating is also simply called carbon-14 dating. Carbon-14 is a radioactive isotope of carbon, with a half-life of 5,730 years (which is very short compared with the above isotopes), and decays into nitrogen. In other radiometric dating methods, the heavy parent isotopes were produced by nucleosynthesis in supernovas, meaning that any parent isotope with a short half-life should be extinct by now. Carbon-14, though, is continuously created through collisions of neutrons generated by cosmic rays with nitrogen in the upper atmosphere and thus remains at a near-constant level on Earth. The carbon-14 ends up as a trace component in atmospheric carbon dioxide (CO2). A carbon-based life form acquires carbon during its lifetime. Plants acquire it through photosynthesis, and animals acquire it from consumption of plants and other animals. When an organism dies, it ceases to take in new carbon-14, and the existing isotope decays with a characteristic half-life (5730 years). The proportion of carbon-14 left when the remains of the organism are examined provides an indication of the time elapsed since its death. This makes carbon-14 an ideal dating method to date the age of bones or the remains of an organism. The carbon-14 dating limit lies around 58,000 to 62,000 years. The rate of creation of carbon-14 appears to be roughly constant, as cross-checks of carbon-14 dating with other dating methods show it gives consistent results.
== Regulation == The GnRHR responds to GnRH as well as to synthetic GnRH agonists. Agonists stimulate the receptor, however prolonged exposure leads to a downregulation effect resulting in hypogonadism, an effect that is often medically utilized. GnRH antagonists block the receptor and inhibit gonadotropin release. GnRHRs are further regulated by the presence of sex hormones as well as activin and inhibin.
==== Harley ==== Ricky Legere fights a bully named Harley, to defend a French kid. The bully only taps out one time in the first round, and stands through the second one, leaving the bully with $9000.
Sources: en.wikipedia.org
== History == The word "cachexia" is derived from the Greek words kakos 'bad' and hexis 'condition'. English ophthalmologist John Zachariah Laurence was the first to use the phrase "cancerous cachexia", doing so in 1858. He applied the phrase to the chronic wasting associated with malignancy. It was not until 2011 that the term "cancer-associated cachexia" was given a formal definition, with a publication by Kenneth Fearon. Fearon defined it as "a multifactorial syndrome characterized by ongoing loss of skeletal muscle (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment".
== Further reading == Dorothy C. Donath (1971). Buddhism for the West: Theravāda, Mahāyāna and Vajrayāna; a comprehensive review of Buddhist history, philosophy, and teachings from the time of the Buddha to the present day. Julian Press. ISBN 0-07-017533-0.
=== Role of cysteinyl leukotrienes === Cysteinyl leukotriene receptors CYSLTR1 and CYSLTR2 are present on mast cells, eosinophil, and endothelial cells. During cysteinyl leukotriene interaction, they can stimulate proinflammatory activities such as endothelial cell adherence and chemokine production by mast cells. As well as mediating inflammation, they induce asthma and other inflammatory disorders, thereby reducing the airflow to the alveoli. The levels of cysteinyl leukotrienes, along with 8-isoprostane, have been reported to be increased in the EBC of patients with asthma, correlating with disease severity. Cysteinyl leukotrienes may also play a role in adverse drug reactions in general and in contrast medium induced adverse reactions in particular. In excess, the cysteinyl leukotrienes can induce anaphylactic shock.
Sources: en.wikipedia.org
指同一个分子能激活 GIP、GLP-1 和胰高血糖素三类受体。它与只激活一到两种受体的同类分子在设计思路上有所区别。这种设计的目的在于覆盖更多代谢调节通路。
天然肽类在体内容易被酶解并快速清除。脂肪酸侧链与非天然氨基酸可以延缓清除、降低酶解速率。修饰后的分子因此更适合较长间隔的给药安排。
公开资料主要来自临床阶段的报告与注册平台记录。这些材料提供的是阶段性信息，而非最终结论。完整的安全性与有效性数据仍在积累中。
Retatrutide is an investigational peptide that activates the GLP-1, GIP, and glucagon receptors at the same time. It is being studied for obesity and type 2 diabetes and has not been approved for clinical use. The internal code LY3437943 refers to the same molecule.